Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS)
CUSIP: 00461U105
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock, $0.00001 par value per share
- Shares outstanding
- 121,058,810
- Total 13F shares
- 28,456,883
- Share change
- -3,663,878
- Total reported value
- $46,099,261
- Price per share
- $1.62
- Number of holders
- 56
- Value change
- -$5,512,533
- Number of buys
- 20
- Number of sells
- 41
Quarterly Holders Quick Answers
What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00461U105:
Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MFN Partners Management, LP |
13F
|
Company |
3.3%
|
4,000,000
|
$4,160,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.6%
|
3,175,636
|
$3,303,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.2%
|
2,626,521
|
$2,732,000 | — | 31 Mar 2020 | |
| Endurant Capital Management LP |
13F
|
Company |
2.2%
|
2,619,187
|
$2,724,000 | — | 31 Mar 2020 | |
| Samsara BioCapital, LLC |
13F
|
Company |
2.2%
|
2,608,117
|
$2,712,000 | — | 31 Mar 2020 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.7%
|
2,087,312
|
$2,171,000 | — | 31 Mar 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.7%
|
2,000,000
|
$2,080,000 | — | 31 Mar 2020 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.6%
|
1,911,573
|
$1,988,000 | — | 31 Mar 2020 | |
| Vivo Capital, LLC |
13F
|
Company |
1.4%
|
1,647,214
|
$1,713,000 | — | 31 Mar 2020 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.3%
|
1,600,000
|
$1,664,000 | — | 31 Mar 2020 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.3%
|
1,537,357
|
$1,599,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
1,400,454
|
$1,457,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.55%
|
667,188
|
$694,000 | — | 31 Mar 2020 | |
| Aisling Capital Management LP |
13F
|
Company |
0.52%
|
634,455
|
$660,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.48%
|
587,094
|
$610,000 | — | 31 Mar 2020 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.41%
|
501,000
|
$521,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.29%
|
355,127
|
$370,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
217,782
|
$227,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
0.17%
|
206,784
|
$215,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.15%
|
179,044
|
$186,000 | — | 31 Mar 2020 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.1%
|
115,839
|
$120,000 | — | 31 Mar 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.09%
|
114,757
|
$119,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.09%
|
110,000
|
$115,000 | — | 31 Mar 2020 | |
| Alambic Investment Management, L.P. |
13F
|
Company |
0.08%
|
98,286
|
$102,000 | — | 31 Mar 2020 | |
| Man Group plc |
13F
|
Company |
0.08%
|
93,518
|
$97,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.07%
|
84,702
|
$89,000 | — | 31 Mar 2020 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.06%
|
69,635
|
$72,000 | — | 31 Mar 2020 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.05%
|
58,726
|
$61,000 | — | 31 Mar 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
57,155
|
$59,000 | — | 31 Mar 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
55,200
|
$57,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
52,350
|
$54,000 | — | 31 Mar 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
51,626
|
$54,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
51,250
|
$53,000 | — | 31 Mar 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
47,336
|
$49,000 | — | 31 Mar 2020 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.04%
|
44,700
|
$46,000 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
39,023
|
$41,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.03%
|
34,700
|
$36,000 | — | 31 Mar 2020 | |
| Creative Planning |
13F
|
Company |
0.02%
|
30,076
|
$31,000 | — | 31 Mar 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
29,649
|
$31,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
24,086
|
$25,000 | — | 31 Mar 2020 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.02%
|
22,266
|
$23,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
18,997
|
$20,000 | — | 31 Mar 2020 | |
| Aperio Group, LLC |
13F
|
Company |
0.02%
|
18,566
|
$19,000 | — | 31 Mar 2020 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.02%
|
18,418
|
$19,000 | — | 31 Mar 2020 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.02%
|
18,241
|
$19,000 | — | 31 Mar 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
18,150
|
$19,000 | — | 31 Mar 2020 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.01%
|
16,490
|
$17,000 | — | 31 Mar 2020 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
0.01%
|
14,000
|
$15,000 | — | 31 Mar 2020 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.01%
|
13,280
|
$14,000 | — | 31 Mar 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.01%
|
11,413
|
$12,000 | — | 31 Mar 2020 |
Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) as of Q2 2020
As of 30 Jun 2020,
Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,456,883 shares.
The largest 10 holders included
MFN Partners Management, LP, RENAISSANCE TECHNOLOGIES LLC, Samsara BioCapital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Sofinnova Investments, Inc., Endurant Capital Management LP, Parkman Healthcare Partners LLC, Vivo Capital, LLC, Rock Springs Capital Management LP, and EcoR1 Capital, LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
65
Q2 2020 holders
56
Holder diff
-9
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.